U.S. Preventive Services Task Force (USPSTF)-Related Articles August 21, 2015

Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: recommendation statement. Am Fam Physician  2015 Jan 15;91(2). [Updates 2005 USPSTF recommendations on genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility, citing AHRQ evidence synthesis, Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA Related Cancer: Systematic Review to Update the U.S. Preventive Services Task Force Recommendation, 2013.] Select to access the abstract.

Miller RA, Waters LL, Mody DR, et al. Squamous cell carcinoma of the cervix: a cytology-histology-human papillomavirus correlation in clinical practice. Arch Pathol Lab Med  2015 Jun;139(6):776-81. [Mentions USPSTF recommendations on screening for cervical cancer.] Select to access the abstract.

Bennett K, Rhodes AE, Duda S, et al. A youth suicide prevention plan for Canada: a systematic review of reviews. Can J Psychiatry  2015 Jun;60(6):245-57. [Cites article by Petitti et al. (Ann Intern Med, 2009) on USPSTF methodologies concerning insufficient evidence.] Select to access the abstract.

Hendry S, Mounsey A. PURLs: Consider these medications to help patients stay sober. J Fam Pract  2015 Apr;64(4):238-40. [Cites USPSTF final recommendation statement, Alchohol Misuse: Screening and Behavioral Interventions in Primary Care, as published on the USPSTF Web site.] Select to access the abstract.

Oyola S, Kirley K. Another good reason to recommend low-dose aspirin. J Fam Pract  2015 May;64(5):301-3. [Summarizes and discusses findings from USPSTF-sponsored evidence review on low-dose aspirin for prevention of morbidity and mortality from pre-eclampsia (Ann Intern Med, 2014).] Select to access the abstract.

Solebo AL, Cumberland PM, Rahi JS. Whole-population vision screening in children aged 4-5 years to detect amblyopia. Lancet  2015 Jun 6;385(9984):2308-19. [Reviews findings from USPSTF-sponsored evidence review on screening for visual impairment in children ages 1-5 years by Chou, Dana, and Bougatsos (Pediatrics, 2011).] Select to access the abstract.